Olmesartan 1 A Pharma (Olmesartan Medoxomil)

Olmesartan medoxil, the active ingredient in Olmesartan 1 A Pharma, is an Angiotensin drug presented as a tablet for oral use. It treats hypertension and is used in adult patients who require blood pressure control. GNH USA supplies Olmesartan 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan medoxil is indicated for the management of high blood pressure within the renin‑angiotensin‑aldosterone system pathway.

- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Diabetic nephropathy (adjunct): helps slow progression of kidney damage when used with other antihypertensives. - Heart failure (adjunct): contributes to blood‑pressure control as part of combination therapy.

Olmesartan medoxil may cause a range of adverse reactions. Monitoring for side effects is part of routine clinical care.

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Diarrhea

Serious or Rare Side Effects: - Angio‑edema - Severe hypotension - Acute kidney injury - Hyperkalemia - Liver enzyme elevation

When prescribing Olmesartan medoxil, clinicians should consider several safety aspects.

- Monitor blood pressure: ensure adequate control without excessive lowering. - Assess renal function: adjust use in patients with impaired kidneys. - Check electrolytes: watch for potassium abnormalities. - Avoid in pregnancy: drug is contraindicated due to fetal risk. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Olmesartan medoxil can interact with several other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Potassium‑sparing diuretics: may cause dangerous hyper‑kalemia. - Aliskiren (in diabetics): heightened risk of renal impairment. - NSAIDs (high dose): can blunt antihypertensive effect and affect kidney function.

Moderate Interactions (Monitor Closely): - ACE inhibitors: combined use may increase risk of hypotension and renal dysfunction. - Lithium: may raise lithium levels, requiring serum monitoring. - Thiazide diuretics: may enhance potassium loss, needing electrolyte checks.